LA Anjaney Ventures

Urofollitropin Injections BP 75 IU are a prescription fertility medicine containing urofollitropin, a form of follicle‑stimulating hormone (FSH) derived from the urine of post‑menopausal women and standardized to 75 international units (IU) per dose. This hormone plays a vital role in human reproduction by stimulating the growth and maturation of ovarian follicles (eggs) in women undergoing fertility treatment and by supporting sperm production in some male infertility protocols when combined with other hormones. Administered by subcutaneous or intramuscular injection under the guidance of a fertility specialist, urofollitropin helps prepare the ovaries for ovulation and can be used in assisted reproductive technologies (ART) such as intrauterine insemination (IUI) or in‑vitro fertilization (IVF) to increase the chances of successful conception. Because its effects directly influence hormone‑mediated processes, close medical monitoring — including ultrasound and hormone level tests — is essential to adjust dosing and minimize risks, such as ovarian hyperstimulation syndrome (OHSS), multiple pregnancy or local injection reactions. Common side effects may include abdominal discomfort, headache, nausea or injection‑site irritation, and treatment should be individualized and supervised by a qualified healthcare provider to ensure safe and effective use.

Additional Information:

• Delivery Time: 10-15 days
• Packaging Details: 1 injection per box